USPTO serial 79288877
RADMAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RADMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
Andrew S. Ehard Merchant & Gould P.C.P.O. Box 2910dockmpls@merchantgould.comMinneapolis, MN 55402-0910Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; all of the foregoing containing monoclonal antibodies | ACTIVE | — |
| 010 | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery devices sold empty being syringes, infusion sets and catheters | ACTIVE | — |
| 042 | Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named RADMAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 14, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 30, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 27, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 24, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 15, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |